Correspondence 0001104659-24-088390 from Semler Scientific, Inc. (SMLR) (CIK 0001554859)
Semler Scientific, Inc. (SMLR) (CIK 0001554859)
Date: Aug. 12, 2024 · CIK: 0001554859 · Accession: 0001104659-24-088390
AI Filing Summary & Sentiment
File numbers found in text: 333-280013
Letter
VIA EDGAR Office of Life Sciences Division of Corporation Finance Attention: Mr. Benjamin Richie Requested Date: August 13, 2024 Requested Time: 4:05 p.m., Eastern Time
Dear Mr. Richie and Ms. Nguyen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), Semler Scientific, Inc. (the “Company”) hereby requests that the effective date of the above-referenced registration statement (the “Registration Statement”) be accelerated to August 13, 2024, at 4:05 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Goodwin Procter LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act.
Once the Registration Statement is effective, please orally confirm the event with our counsel, Goodwin Procter LLP, by calling Marianne Sarrazin at (415) 733-6134.
If you have any questions regarding this request, please contact Marianne Sarrazin of Goodwin Procter LLP at (415) 733-6134.
Sincerely,
SEMLER SCIENTIFIC, INC.
Show Raw Text
CORRESP
1
filename1.htm
August 12, 2024
VIA EDGAR
Office of Life Sciences
Division of Corporation Finance
U.S. Securities and Exchange Commission
100 F Street, NE
Washington, DC 20549
Attention:
Mr. Benjamin Richie
Ms. Lauren Nguyen
Re:
Semler Scientific, Inc.
Acceleration Request for Registration Statement on Form S-3
File No. 333-280013
Acceleration Request
Requested Date:
August 13, 2024
Requested Time:
4:05 p.m., Eastern Time
Dear Mr. Richie and Ms. Nguyen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the
“Act”), Semler Scientific, Inc. (the “Company”) hereby requests that the effective date of the above-referenced
registration statement (the “Registration Statement”) be accelerated to August 13, 2024, at 4:05 p.m., Eastern Time,
or as soon thereafter as practicable, unless we or our outside counsel, Goodwin Procter LLP, request by telephone that such Registration
Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of
its responsibilities under the Act.
Once the Registration Statement is effective, please orally confirm
the event with our counsel, Goodwin Procter LLP, by calling Marianne Sarrazin at (415) 733-6134.
If you have any questions regarding this request, please contact Marianne
Sarrazin of Goodwin Procter LLP at (415) 733-6134.
Sincerely,
SEMLER SCIENTIFIC, INC.
/s/ Douglas Murphy-Chutorian, M.D.
Douglas Murphy-Chutorian, M.D.
Chief Executive Officer
cc:
Renae Cormier, Semler Scientific, Inc.
Marianne Sarrazin, Esq., Goodwin Procter LLP